TALEN

TALEN1-zar1

ID

ZDB-TALEN-161121-2

Name

TALEN1-zar1

Previous Names

None

Target

zar1 (1)

Target Sequence 1

5' - GCCAGCCGGCTAAGC - 3'

Target Sequence 2

5' - GTTATCGACTGTCT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
gd5	zar1

Expression

Gene expression in Wild Types + TALEN1-zar1

No data available

Phenotype

Phenotype resulting from TALEN1-zar1

No data available

Phenotype of all Fish created by or utilizing TALEN1-zar1

Phenotype	Fish	Conditions	Figures
ovary zp3f.1 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
ovary zp3a.2 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
ovary zp3.2 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
ovary ddit3 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 6 from Miao et al., 2017
oocyte cortical granule increased size, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 3 from Miao et al., 2017
ovary zpax1 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
female organism present, ameliorated	zar1^gd5/gd5 (TU)	chemical treatment by environment: 17alpha-ethynylestradiol	Fig. 5 from Miao et al., 2017
female organism absent, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 3 from Miao et al., 2017
ovary pdia4 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 6 from Miao et al., 2017
female organism absent, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 2 , Fig. 6 from Miao et al., 2017
ovary zpax4 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
oocyte cortical granule decreased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 3 from Miao et al., 2017
ovary zp3b expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
ovary atf3 expression amount, ameliorated	zar1^gd5/gd5 (TU)	chemical treatment by environment: 17alpha-ethynylestradiol	Fig. 5 from Miao et al., 2017
ovary dnajc3a expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 6 from Miao et al., 2017
female sex determination occurrence, ameliorated	zar1^gd5/gd5 (TU)	chemical treatment by environment: EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor	Fig. 6 from Miao et al., 2017
female sex determination arrested, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 2 , Fig. 3 , Fig. 6 from Miao et al., 2017
ovary absent, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 2 , Fig. 3 from Miao et al., 2017
gonad zar1 expression absent, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 1 from Miao et al., 2017
oocyte growth arrested, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 3 from Miao et al., 2017
ovary vapb expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 6 from Miao et al., 2017
ovary apoptotic process increased process quality, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 4 from Miao et al., 2017
ovary btg2 expression decreased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 5 from Miao et al., 2017
ovary atf3 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	control	Fig. 5 from Miao et al., 2017
female sex determination arrested, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 3 from Miao et al., 2017
female sex determination occurrence, ameliorated	zar1^gd5/gd5 (TU)	chemical treatment by environment: 17alpha-ethynylestradiol	Fig. 5 from Miao et al., 2017
female organism present, ameliorated	zar1^gd5/gd5 (TU)	chemical treatment by environment: EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor	Fig. 6 from Miao et al., 2017
ovary zp2l1 expression increased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
ovary zp2l1 expression decreased amount, abnormal	zar1^gd5/gd5 (TU)	standard conditions	Fig. 7 from Miao et al., 2017
male organism decreased amount, abnormal	zar1^gd5/+ (TU)	chemical treatment by environment: 17alpha-ethynylestradiol	Fig. 5 from Miao et al., 2017
female organism absent, abnormal	tp53^zdf1/+; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
ovary apoptotic process increased occurrence, abnormal	tp53^zdf1/+; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
oocyte growth arrested, abnormal	tp53^zdf1/+; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
female sex determination arrested, abnormal	tp53^zdf1/+; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
female sex determination occurrence, ameliorated	tp53^zdf1/zdf1; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
oocyte growth occurrence, ameliorated	tp53^zdf1/zdf1; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
female organism present, ameliorated	tp53^zdf1/zdf1; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
ovary apoptotic process occurrence, ameliorated	tp53^zdf1/zdf1; zar1^gd5/gd5	standard conditions	Fig. 4 from Miao et al., 2017
ovary present, ameliorated	zar1^gd5/gd5; gd14Tg	standard conditions	Fig. 2 from Miao et al., 2017
female organism present, ameliorated	zar1^gd5/gd5; gd14Tg	standard conditions	Fig. 2 from Miao et al., 2017
female sex determination occurrence, ameliorated	zar1^gd5/gd5; gd14Tg	standard conditions	Fig. 2 from Miao et al., 2017

Citations